Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?

被引：0
|
作者：
Schaefer, Jordan K. [1 ]
Barnes, Geoffrey D. [2 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2024年 / 124卷 / 08期
关键词：
WARFARIN; NONADHERENCE; MANAGEMENT; ADHERENCE;
D O I：
10.1055/s-0044-1787299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：791 / 794
页数：4
相关论文
共 50 条
  • [21] Direct oral anticoagulants compared to vitamin-K antagonist for the management of left ventricular thrombus
    Straw, S. Sam
    Iqbal, H.
    Craven, T.
    Stirling, K.
    Wheatcroft, S.
    Witte, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 51 - 51
  • [22] Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation
    Hohmann, Christopher
    Pfister, Roman
    Frerker, Christian
    Beckmann, Andreas
    Walther, Thomas
    Bleiziffer, Sabine
    Ensminger, Stephan
    Bekeredjian, Raffi
    Seiffert, Moritz
    Sinning, Jan-Malte
    Moellmann, Helge
    Beyersdorf, Friedhelm
    Baldus, Stephan
    Boening, Andreas
    Herrmann, Eva
    Balaban, Uemniye
    Kuhn, Elmar
    GARY Executive Board
    HEART, 2023, 109 (22) : 1706 - 1713
  • [23] Non-vitamin K antagonist oral anticoagulants and sport
    Romano, Silvio
    Salustri, Elisa
    Robles, Antonio G.
    Calo, Leonardo
    Penco, Maria
    Sciarra, Luigi
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (02): : 98 - 109
  • [24] Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis
    Lee, Grace K. H.
    Chen, Vanessa H.
    Tan, Choon-Han
    Leow, Aloysius S. T.
    Kong, Wan-Yee
    Sia, Ching-Hui
    Chew, Nicholas W. S.
    Tu, Tian-Ming
    Chan, Bernard P. L.
    Yeo, Leonard L. L.
    Sharma, Vijay K.
    Tan, Benjamin Y. Q.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (03) : 724 - 731
  • [25] Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
    Steffel, Jan
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0I) : I32 - I37
  • [26] Development of a Tool to Identify Patients' Preference for Vitamin K Antagonist or Direct Oral Anticoagulant Therapy
    Zolfaghari, Shabnam
    Harenberg, Job
    Froelich, Lutz
    Wehling, Martin
    Weiss, Christel
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (01): : 121 - 128
  • [27] Therapy education for patients receiving oral anticoagulants vitamin K antagonists
    Satger, Bernadette
    Blaise, Sophie
    Fontaine, Michele
    Yver, Jacqueline
    Allenet, Benoit
    Baudrant, Magali
    Pernod, Gilles
    Bosson, Jean-Luc
    PRESSE MEDICALE, 2009, 38 (12): : 1780 - 1787
  • [28] Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study
    Salmasi, Shahrzad
    Safari, Abdollah
    De Vera, Mary A.
    Hoegg, Tanja
    Lynd, Larry D.
    Koehoorn, Mieke
    Barry, Arden R.
    Andrade, Jason G.
    Deyell, Marc W.
    Rush, Kathy L.
    Zhao, Yinshan
    Loewen, Peter
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (03) : 437 - 444
  • [29] Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study
    Shahrzad Salmasi
    Abdollah Safari
    Mary A. De Vera
    Tanja Högg
    Larry D. Lynd
    Mieke Koehoorn
    Arden R. Barry
    Jason G. Andrade
    Marc W. Deyell
    Kathy L. Rush
    Yinshan Zhao
    Peter Loewen
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 437 - 444
  • [30] Comparison of the Effectiveness and Safety of Direct Oral Anticoagulants With the Vitamin K Antagonist Warfarin in Patients With Atrial Fibrillation and Active Cancer
    Yasui, Taku
    Shioyama, Wataru
    Oboshi, Makiko
    Oka, Toru
    Fujita, Masashi
    CIRCULATION, 2018, 138
12345